A股异动丨跌落神坛!“药茅”片仔癀股价创逾5年新低,市值较高位蒸发超60%

Group 1 - The stock price of Pianzaihuang (600436.SH), once reaching 473 yuan and a market capitalization close to 300 billion yuan, has significantly declined to 170 yuan, marking a new low since July 2020, with a market cap now at 102.5 billion yuan, representing a loss of over 60% from its peak [1] - Pianzaihuang, previously dubbed the "Moutai of medicine," has seen its product price drop from a peak of 1600 yuan per unit to 760 yuan on e-commerce platforms, indicating a complete collapse of its price bubble and a sharp decline in market interest [1] - In the third quarter of this year, Pianzaihuang reported revenue, net profit, and net profit excluding non-recurring items of 2.064 billion yuan, 687 million yuan, and 438 million yuan, respectively, reflecting year-on-year declines of 26.28%, 28.82%, and 54.6% [1]